Tasimelteon — Blue Cross Blue Shield Of New Mexico
5 indications indexed for this drug.
- Nighttime Sleep Disturbances Associated With Smith Magenis SView coverage criteria
- Non 24 Hour Sleep Wake Disorder In Totally Blind Patients NoView coverage criteria
- Other Fda Labeled Indication For Requested Agent And Route OView coverage criteria
- Other Indication Supported In Compendia For The Requested AgView coverage criteria
- Quantity Limit CriteriaView coverage criteria